Dollar strains Novo profits 4:24 Interview
Nov. 15 - The CFO of the world's biggest maker of insulin Novo Nordisk (NOVOb.CO) says the weak dollar is having a ''very very significant strain'' on the Denmark-based company.
Playing Next
Jobless claims up, labor market still healing
WASHINGTON (Reuters) - The number of workers filing new applications for jobless insurance unexpectedly rose last week, according to government data on Thursday that still suggested the labor market was improving.
U.N. talks at "critical juncture"
Climate talks were given a second chance after the U.S. backed a $100 billion global fund to support poor countries. What else will it take to hammer out a deal? Full Article
Death of a salesman
Old-style sales reps may be fading thanks to a shift in the pharmaceutical market that has created a new gatekeeper in drug sales. Full Article










